- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01183793
Magnetic Resonance (MR) Enterography Assessment of Post Operative Small Bowel Length in Short Bowel Syndrome Patients
MR Enterography Assessment of Post Operative Small Bowel Length in Short Bowel Syndrome Patients
It is essential to know intestinal length and anastomotic type in post-operative short bowel syndrome patients. These parameters can help predict long-term intestinal failure with long-term parenteral nutrition usually needed for smallest lengths. Sometimes these parameters are unfortunately missing for lack of intraoperative measurement. Thus, it is necessary to develop non-invasive and reproducible techniques to assess small bowel length. This is the reason why the investigators will evaluate magnetic resonance (MR)-enterography and barium follow-through in this indication. There are at this time only two small studies evaluating barium follow-through for intestinal length measurement, and none evaluating MR-enterography. However, a major advantage of the latter is the lack of radiation exposure and possibility to perform 3D.
This will be an open labelled single center crossover study. Short bowel syndrome patients of the investigators center will be included after consent. The sequence of exams (MR enterography followed by barium follow-through or vice-versa) will be randomly assigned. Peroperative short bowel length measurement will be available for all patients. There will be one month between the two exams.
The main objective of this study is to assess the performance of MR-enterography in short bowel measurement in short bowel syndrome patients, the gold standard being peroperative length. Secondary objectives are to assess the performance of barium follow-through in short bowel measurement in these patients, and to show that barium follow-through does not perform better than MR-enterography. For that purpose the investigators will include 50 patients over 2 years.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Nice, France, 06000
- Recruiting
- Service d'Hépato-Gastroentérologie et Nutrition Clinique - CHU Nice - hôpital Archet 2
-
Contact:
- SCHNEIDER Stephane, PU-PH
- Phone Number: 0033 4 92 03 60 18
- Email: schneider.s@chu-nice.fr
-
Contact:
- EVESQUE Ludovic, Ph
- Email: evesque.l@chu-nice.fr
-
Principal Investigator:
- SCNEIDER Stephane, PU-PH
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Intraoperative small bowel length < 200 cm
- Males and females between 18 and 85 years of age
- Patient with social insurance
- Signature of informed consent
Exclusion Criteria:
- Allergy to contrast product
- Enterostomy closure expected within 2 months after randomization
- Pregnancy or breast feeding woman
- Swallowing disorders
- Deprivation of liberty
- Contraindications to magnetic resonance imaging (pace-maker, metal implant, known allergy to gadolinium)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Bras pair
MR-enterography then barium follow through
|
Assessment of the lack of difference between surgical and MR enterography small bowel length measurement with a comparison sample test
|
|
Other: Bras impair
Barium follow-through then MR-enterography
|
Assessment of the lack of difference between surgical and MR enterography small bowel length measurement with a comparison sample test
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Assessment of the lack of difference between surgical and MR enterography small bowel length measurement with a comparison sample test
Time Frame: at 3 months
|
at 3 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Assessment of the lack of difference between surgical and barium follow through small bowel length measurement with a comparison sample test
Time Frame: at 3 months
|
at 3 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: SCHNEIDER Stephane, PU-PH, Services d'Hépato-Gastroentérologie et Nutrition Clinique
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 09-CIR-02
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Short Bowel Syndrome
-
Marathon Pharmaceuticals, LLCWithdrawnShort Bowel Syndrome | Short Gut Syndrome | SBS | Short Gut | Short BowelUnited States
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingShort Bowel Syndrome (SBS)
-
Meyer Children's Hospital IRCCSRecruiting
-
TakedaRecruitingShort Bowel Syndrome (SBS)China
-
Jinling Hospital, ChinaRecruitingIntestinal Failure | Short Bowel Syndrome (SBS)China
-
Central Hospital, Nancy, FranceBeaujon Hospital; Société Francophone Nutrition Clinique et MétabolismeUnknownSBS - Short Bowel SyndromeFrance
-
TakedaCompletedShort Bowel Syndrome (SBS)Brazil
-
TakedaCompletedShort Bowel Syndrome (SBS)Canada
-
GlyPharma TherapeuticsVectivBio AGCompletedSBS - Short Bowel SyndromeDenmark
-
Zealand PharmaEnrolling by invitationShort Bowel Syndrome (SBS)Germany, United States, Belgium, Canada, France, Poland, United Kingdom
Clinical Trials on Barium follow-through and MR-enterography
-
Mayo ClinicMedtronic - MITGCompletedCrohn's DiseaseUnited States
-
University College, LondonBritish Society of Gastrointestinal and Abdominal Radiology (BSGAR)Recruiting
-
University of California, Los AngelesCarnegie Mellon UniversityCompleted
-
Mayo ClinicNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedHealthyUnited States
-
Hospices Civils de LyonCompletedPeripheral Arterial Occlusive Disease | Critical Limb Ischemia | Arterial Revascularization | Arterial Bypass SurgeryFrance
-
Pontificia Universidad Catolica de ChileNot yet recruitingAnesthesia | Regional Anesthesia Success | Regional Anesthesia | Anesthesia , AnalgesiaChile
-
Rennes University HospitalCompletedLeft Ventricular Assist Devices PatientsFrance
-
University of Michigan Rogel Cancer CenterAgency for Healthcare Research and Quality (AHRQ)RecruitingMalignant Solid Neoplasm | Breast Carcinoma | Lung Carcinoma | Colorectal Carcinoma | Prostate CarcinomaUnited States
-
Hellenic Society of Obstetrics and GynecologyNational and Kapodistrian University of Athens; St George's, University of... and other collaboratorsCompleted
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingCancer Survivor | Prostate CarcinomaUnited States